4th Quarter - Report

AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN

Firm
Client
Income
—
Expenses
$1,319,853
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises, access to clinical laboratory services via telehealth clinical visits. Saving Access to Laboratory Services Act H.R. 8188/S. 4449, VALID Act H.R. 4128/S. 2209, Telehealth Extension and Evaluation Act S. 3593, PREVENT Pandemics Act S. 3799, Consolidated Appropriations Act, 2023, P.L 117-328.

LobbyistCovered position, as disclosed
HOLLY GROSHOLZ New —
THOMAS B SPARKMAN —
SUSAN VAN METER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Bills named: H.R. 4128 (117th), S. 3799 (117th), S. 4449 (117th), S. 3593 (117th), H.R. 8188 (117th), S. 2209 (117th)

Medicare/Medicaid MMM

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises, access to clinical laboratory services via telehealth clinical visits. Saving Access to Laboratory Services Act H.R. 8188/S. 4449, VALID Act H.R. 4128/S. 2209, Telehealth Extension and Evaluation Act S. 3593, PREVENT Pandemics Act S. 3799, Consolidated Appropriations Act, 2023, P.L 117-328.

LobbyistCovered position, as disclosed
HOLLY GROSHOLZ New —
THOMAS B SPARKMAN —
SUSAN VAN METER —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 4128 (117th), S. 2209 (117th), S. 3799 (117th), H.R. 8188 (117th), S. 4449 (117th), S. 3593 (117th)

Budget/Appropriations BUD

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises, access to clinical laboratory services via telehealth clinical visits. Saving Access to Laboratory Services Act H.R. 8188/S. 4449, VALID Act H.R. 4128/S. 2209, Telehealth Extension and Evaluation Act S. 3593, PREVENT Pandemics Act S. 3799, Consolidated Appropriations Act, 2023, P.L 117-328.

LobbyistCovered position, as disclosed
HOLLY GROSHOLZ New —
THOMAS B SPARKMAN —
SUSAN VAN METER —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); White House Office; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC)

Bills named: S. 4449 (117th), S. 3799 (117th), H.R. 8188 (117th), S. 3593 (117th), S. 2209 (117th), H.R. 4128 (117th)

Health Issues HCR

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises, access to clinical laboratory services via telehealth clinical visits. Saving Access to Laboratory Services Act H.R. 8188/S. 4449, VALID Act H.R. 4128/S. 2209, Telehealth Extension and Evaluation Act S. 3593, PREVENT Pandemics Act S. 3799, Consolidated Appropriations Act, 2023, P.L 117-328.

LobbyistCovered position, as disclosed
HOLLY GROSHOLZ New —
THOMAS B SPARKMAN —
SUSAN VAN METER —

Contacted: Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); White House Office

Bills named: H.R. 8188 (117th), S. 4449 (117th), H.R. 4128 (117th), S. 3799 (117th), S. 2209 (117th), S. 3593 (117th)

Disaster Planning/Emergencies DIS

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. Saving Access to Laboratory Services Act H.R. 8188/S. 4449, VALID Act H.R. 4128/S. 2209, PREVENT Pandemics Act S. 3799, Consolidated Appropriations Act, 2023, P.L 117-328.

LobbyistCovered position, as disclosed
HOLLY GROSHOLZ New —
THOMAS B SPARKMAN —
SUSAN VAN METER —

Contacted: Centers For Disease Control & Prevention (CDC); White House Office; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 4449 (117th), S. 2209 (117th), S. 3799 (117th), H.R. 8188 (117th), H.R. 4128 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.